SCHEMBL24495338

SCHEMBL24495338

CCCCNC(=O)N(CC=C(c1ccccc1)c1ccccc1)[C@H](C)c1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
MTNR1A P48039 2/20 0.40
MTNR1B P49286 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 2/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
MAPT P10636 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
CHRM5 P08912 1/20 0.38
PDE5A O76074 1/20 0.38
CASR P41180 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
BMP1 P13497 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24495135 0.90 L3MBTL1 (0.43) CNR1CNR2MTNR1AMTNR1BL3MBTL1
SCHEMBL24495121 0.83 NPY5R (0.49) MAPTCASR
SCHEMBL24495295 0.82 L3MBTL1 (0.42) CNR1CNR2MTNR1AMTNR1BL3MBTL1
SCHEMBL24495331 0.82 MEN1 (0.48) MTNR1AMTNR1BL3MBTL1MAPTHSD17B10
SCHEMBL24495113 0.79 L3MBTL1 (0.44) CNR1CNR2MTNR1AMTNR1BL3MBTL1
SCHEMBL24495181 0.79 TSHR (0.46) MTNR1AMTNR1BL3MBTL1MAPTCHRM5
SCHEMBL24495071 0.79 L3MBTL1 (0.44) MTNR1AMTNR1BL3MBTL1MAPTHSD17B10
SCHEMBL24495073 0.78 YAP1 (0.49) MAPT
SCHEMBL24495396 0.78 L3MBTL1 (0.40) MTNR1AMTNR1BL3MBTL1MAPT
SCHEMBL24495292 0.77 L3MBTL1 (0.43) CNR1CNR2MTNR1AMTNR1BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-20220177440-A1 Fendiline Derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2022-06-09 US disclosed
US-20220177440-A1 Fendiline Derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043602-B2 Fendiline derivatives CYP11B2, CYP3A7, CYP4F2 CNR1 627/4885CNR2 485/4885MTNR1A 204/4885
US-20220177440-A1 Fendiline Derivatives CYP11B2, CYP3A7, CYP4F2 CNR1 627/4885CNR2 485/4885MTNR1A 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.